Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/26/2005 | EP1588708A1 Process for producing coated preparation |
10/26/2005 | EP1588707A1 Stable solid medicinal composition for oral administration |
10/26/2005 | EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors. |
10/26/2005 | EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections |
10/26/2005 | EP1588701A2 Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities |
10/26/2005 | EP1588700A1 Biofunctional polymers prepared in supercritical fluid |
10/26/2005 | EP1588699A2 Container with multi-phase composition for use in diagnostic and therapeutic applications |
10/26/2005 | EP1588698A2 A process for the production and screening of materials for use in pharmaceutical aerosol formulations |
10/26/2005 | EP1588697A1 Emulsion gel for topical application of pharmaceuticals |
10/26/2005 | EP1588692A1 Durable foamed composition |
10/26/2005 | EP1587869A2 Membrane active polymers |
10/26/2005 | EP1587823A2 Protein and peptide delivery to mammalian cells in vitro |
10/26/2005 | EP1587564A2 Capsule for receiving an active substance which is administrable by inhalation |
10/26/2005 | EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
10/26/2005 | EP1587519A2 Treatment of cancer with 2-deoxyglucose |
10/26/2005 | EP1587517A1 Anti-protozoal compositions comprising diclazuril |
10/26/2005 | EP1587514A1 A rapid-acting pharmaceutical composition |
10/26/2005 | EP1587504A1 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
10/26/2005 | EP1587503A1 Disposable package for liquid, pasty or powder product |
10/26/2005 | EP1587501A1 Simple tablet compression using gelatin |
10/26/2005 | EP1587500A2 Compounds for oral dosage of active substances requiring a taste masking |
10/26/2005 | EP1587499A1 Nanoparticulate topiramate formulations |
10/26/2005 | EP1587498A1 Powder pharmaceutical compositions |
10/26/2005 | EP1587497A1 Method for producing an immediately decomposing oral form of administration which releases active ingredients |
10/26/2005 | EP1587496A1 Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles |
10/26/2005 | EP1587484A2 Method of treating angiogenic tissue growth |
10/26/2005 | EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use |
10/26/2005 | EP1587478A2 Pharmaceutical composition |
10/26/2005 | EP1587477A2 Odorless formulation for treating mucosal discontinuities |
10/26/2005 | EP1587470A2 Improved formulations for transmucosal vaginal delivery of bisphosphonates |
10/26/2005 | EP1587375A1 Novel compositions comprising carotenoids |
10/26/2005 | EP1534213A4 Water-based delivery systems |
10/26/2005 | EP1534072A4 Anthelmintic oral homogeneous veterinary pastes |
10/26/2005 | EP1463492B1 Adhesive and binding agent for dermal or transdermal treatment systems |
10/26/2005 | EP1423109B1 Compositions comprising pectin and ascorbic acid |
10/26/2005 | EP1408935B1 Process for the preparation of medicated gums |
10/26/2005 | EP1397133B1 Rapid onset formulation |
10/26/2005 | EP1368001B1 Pharmaceutical formulation comprising bicalutamide |
10/26/2005 | EP1365713B1 Urine incontinence device |
10/26/2005 | EP1363641B1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising the same, methods for making same and uses thereof |
10/26/2005 | EP1361881B1 Steroid hormone products and methods for preparing them |
10/26/2005 | EP1328236A4 Methods of decreasing or preventing pain using spicamycin derivatives |
10/26/2005 | EP1282398B1 Inhalation therapy decongestant with foraminous carrier |
10/26/2005 | EP1280507B1 Eutectic mixtures in cosmetic compositions |
10/26/2005 | EP1265618B1 Anaesthetic compositions comprising alfaxalone |
10/26/2005 | EP1263392B1 Clear water-in-oil emulsions |
10/26/2005 | EP1242048B1 Inhalation particles |
10/26/2005 | EP1212092B1 High viscosity liquid controlled delivery system and medical or surgical device |
10/26/2005 | EP1173263B1 A method of spray drying and a plant therefore as well as a partic ulate material obtained by the method |
10/26/2005 | EP1163234B1 Pharmaceutical formulations with improved aqueous solubility |
10/26/2005 | EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1 |
10/26/2005 | EP1107762B1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
10/26/2005 | EP1082107B1 Controlled release lipoic acid |
10/26/2005 | EP1073415B1 Pharmaceutical compositions capable of being gelled |
10/26/2005 | EP1035842B1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION |
10/26/2005 | EP1034793B1 Preventives/remedies for glaucoma |
10/26/2005 | EP0984785B1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits |
10/26/2005 | EP0975357B1 Transdermal delivery system |
10/26/2005 | EP0889710B2 Improvements in or relating to encapsulation |
10/26/2005 | EP0825879B1 Process for the depyrogenation of injectable pharmaceutical solutions |
10/26/2005 | EP0687301B1 Prohormone convertase transformed cells and polypeptide synthesis |
10/26/2005 | CN1688345A Composition with stabilized redox properties and method of stabilization of redox properties |
10/26/2005 | CN1688339A Formulation of human antibodies for treating TNF-alpha associated disorders |
10/26/2005 | CN1688334A Improved bacterial outer membrane vesicles |
10/26/2005 | CN1688321A Composition for treating hemorrhoids |
10/26/2005 | CN1688313A Orally dispersible pharmaceutical piribedil composition |
10/26/2005 | CN1688304A Formulations comprising a basic indolinone compound |
10/26/2005 | CN1688296A Injectable 2, 6-diisopropylphenol-containing anesthetic composition and methods |
10/26/2005 | CN1688295A Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
10/26/2005 | CN1688294A Enteric composition for the manufacture of soft capsule wall |
10/26/2005 | CN1688293A Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
10/26/2005 | CN1688292A Taste masked dosage forms and processes for their preparation |
10/26/2005 | CN1688291A Immediate release dosage forms containing solid drug dispersions |
10/26/2005 | CN1688290A Cannabinoid liquid formulations for mucosal amdinistration |
10/26/2005 | CN1688288A Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole |
10/26/2005 | CN1688279A Oral composition providing enhanced oral hygiene properties |
10/26/2005 | CN1688275A Process for the production of microspheres and unit therefor |
10/26/2005 | CN1688270A Topical patch and reagent kit containing a delayed-type hypersensitivity inducer |
10/26/2005 | CN1688267A Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
10/26/2005 | CN1687118A Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome |
10/26/2005 | CN1686089A Xylitol granule capable of directly being pressed into tablet and its preparation method |
10/26/2005 | CN1686088A Method of raising solubility of film agnet type medicine and medicine utility |
10/26/2005 | CN1686087A Nano-magnetic medicinal microglobule, its preparation method and application |
10/26/2005 | CN1686086A Biodegradable polyester fluorouracil microglobule and its preparation method |
10/26/2005 | CN1224479C Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod |
10/26/2005 | CN1224424C Thermosetting medical carrier composition with mucosa adsorption |
10/26/2005 | CN1224418C Biological preparation containing marine active substance and use thereof |
10/26/2005 | CN1224416C Chinese medicine for treating keloid |
10/26/2005 | CN1224414C Suppository for treating gynecopathy and its preparation technology |
10/26/2005 | CN1224413C Chinese medicine granule preparation for curing stomatocace |
10/26/2005 | CN1224411C Freeze-dried powder injection of Corydalis thalictrifolia franch for curing hepatitis, large dise transfusion medicine preparation method |
10/26/2005 | CN1224406C Medical ointment for treating athlete's foot |
10/26/2005 | CN1224396C Pharmaceutical for treating cardiovascular and cerebrovascular disease |
10/26/2005 | CN1224393C Process for preparing selenium aspirin enteric tablet and its use of resisting thrombosis |
10/26/2005 | CN1224387C Oral preparation of Tegaserod or its acid salt and its preparing process |
10/26/2005 | CN1224383C Blood sugar reducing compound |
10/26/2005 | CN1224382C Method for preparing medicine for relieving cough and reducing sputum |
10/26/2005 | CN1224381C Method for prepaing fast-dispersing dosage forms containing fish gelatin |
10/26/2005 | CN1224380C Method for reducing residual organic solvent in microparticles and use in preparation of medicine thereof |
10/26/2005 | CN1224379C Liquisolid system and method of preparing the same |